Shopping Cart
- Remove All
- Your shopping cart is currently empty
Q134R, a neuroprotective derivative of hydroxyquinoline, effectively inhibits nuclear factor of activated T-cell (NFAT) signaling and possesses the ability to cross the blood-brain barrier. This compound shows promise for research into Alzheimer’s disease (AD) and aging-related disorders[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $916 | 6-8 weeks | |
50 mg | $1,190 | 6-8 weeks | |
100 mg | $1,860 | 6-8 weeks |
Description | Q134R, a neuroprotective derivative of hydroxyquinoline, effectively inhibits nuclear factor of activated T-cell (NFAT) signaling and possesses the ability to cross the blood-brain barrier. This compound shows promise for research into Alzheimer’s disease (AD) and aging-related disorders[1]. |
In vitro | Q134R (1-10 μM) effectively inhibits NFAT signaling without impacting calcineurin function. It achieves partial suppression of NFAT activity in primary rat astrocytes without hindering the calcineurin-mediated dephosphorylation of non-NFAT targets, both in vivo and in vitro[1]. |
In vivo | Q134R (4 mg/kg; orally gavage; twice daily; for 7 days) treatment enhances cognitive function in rodent models of AD-like pathology[1]. |
Alias | Q134R |
Molecular Weight | 410.39 |
Formula | C22H17F3N4O |
Cas No. | 2022949-46-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.